AMENDED AND RESTATED SECRETED PROTEIN DEVELOPMENT AND COLLABORATION AGREEMENT BETWEEN DELTAGEN, INC., AND NUVELO, INC.Development and Collaboration Agreement • May 10th, 2004 • Nuvelo Inc • In vitro & in vivo diagnostic substances
This Amended and Restated Secreted Protein Development and Collaboration Agreement (“Restated Agreement”) is made and entered into as of the Effective Date (defined below), by and between Deltagen, Inc., a Delaware corporation (hereinafter referred to as “Deltagen”), and Nuvelo, Inc., a Nevada corporation, as successor in interest to Hyseq, Inc. (hereinafter referred to as “Nuvelo”), with reference to the following facts and recitals. Deltagen and Nuvelo are referred to collectively hereinafter as the “Parties,” and individually as a “Party.”
